All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Human Stem Cells Institute earnings schedule

Human Stem Cells Institute quarterly earnings, ISKJ.ME earnings report for 2024. When does Human Stem Cells Institute report earnings?
Add to widgets
Added to widgets

When does Human Stem Cells Institute report earnings?

Human Stem Cells Institute reports earnings every quartal, last Human Stem Cells Institute earnings report date was 29/08/2018.

How much is Human Stem Cells Institute earnings per share?

Human Stem Cells Institute estimated earnings per share was 0.46 р. last time.

When is Human Stem Cells Institute next earnings report?

Next Human Stem Cells Institute earnings call will be in August 2024.

Human Stem Cells Institute earnings per share of a financial organization is a calculated indicator of the success of a company, tied to the value of the organization itself. Earnings per share are calculated according to the formula: the amount of the company's profit for the financial period according to official reports is divided by the number of shares in the company. Human Stem Cells Institute earnings per share are calculated for each financial interval. Profit of Human Stem Cells Institute - total profit for the reporting financial period.

Show:
to

Human Stem Cells Institute earnings report

Profits for the entire company Human Stem Cells Institute is more important to managing managers than shareholders of the company. A much more interesting indicator is earnings per share, which directly affects the amount of dividends per share. The date of the profit report Human Stem Cells Institute is tied to the legislation of the country of registration of the company. Each date of Human Stem Cells Institute profit statement corresponds to a line in the service table.

Human Stem Cells Institute quarterly earnings

Earnings per share Human Stem Cells Institute is calculated according to the formula: net income divided by the total number of shares in the company. Earnings per share Human Stem Cells Institute is an indicator of a certain financial interval. It is easy to guess that the financial period coincides with the publication of financial statements of profit. Human Stem Cells Institute earnings per share for the last reporting period can be found in our table (the top row) or graph (the rightmost column). Human Stem Cells Institute quarterly earnings for financial analytics is the main interim report for the financial year.

ISKJ.ME earnings date Estimated EPS
A company's earnings per share, or EPS, is calculated by dividing net income (or profits) to the number of company's shares.
Change for a year %
29/08/2018 0.46 RUB -
03/05/2018 -0.97 RUB -
01/12/2017 0.35 RUB -
29/08/2017 -0.34 RUB -
09/06/2017 -0.28 RUB -
28/04/2017 -0.09 RUB -

Human Stem Cells Institute quarterly earnings per share is also one of the organization’s profitability indicators, although less popular than annual earnings per share. Last quarterly profit Human Stem Cells Institute today is the officially declared profit for the last reference quarter. Change in profit Human Stem Cells Institute for the year is a calculated value for additional information that shows the change in percentage of profit with the same interval of the last year. The change in quarterly profit of Human Stem Cells Institute is a less significant value relative to the change in annual profit of Human Stem Cells Institute.

For convenience of perception and analysis, we publish the change in profit as a percentage. The profit history of Human Stem Cells Institute for the past years and reporting periods is in the table “Quarterly profit”. Human Stem Cells Institute quarterly earnings history database is visible online over the past decade. Human Stem Cells Institute online profit database for past time intervals is compiled from verified official sources throughout the entire time.

Human Stem Cells Institute stocks data

Human Stem Cells Institute financials